Compare GNS & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNS | RPID |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 34.7M |
| IPO Year | 2021 | 2021 |
| Metric | GNS | RPID |
|---|---|---|
| Price | $0.49 | $0.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.17 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 09-28-2026 | 11-16-2026 |
| Dividend Yield | ★ 197.24% | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | $127.02 | $14.93 |
| Revenue Next Year | $36.19 | $18.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $0.09 | $0.58 |
| 52 Week High | $0.83 | $4.94 |
| Indicator | GNS | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 90.23 | 44.20 |
| Support Level | $0.36 | $0.58 |
| Resistance Level | N/A | $0.79 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 59.66 | 74.26 |
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.